IRIS
KLAIN, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.786
AS - Asia 5.623
EU - Europa 3.907
SA - Sud America 705
Continente sconosciuto - Info sul continente non disponibili 238
AF - Africa 142
OC - Oceania 5
Totale 16.406
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.498
SG - Singapore 2.542
RU - Federazione Russa 1.743
CN - Cina 1.106
VN - Vietnam 883
IT - Italia 777
BR - Brasile 546
HK - Hong Kong 455
DE - Germania 242
FR - Francia 213
UA - Ucraina 173
CA - Canada 168
FI - Finlandia 157
GB - Regno Unito 143
NL - Olanda 128
IN - India 127
BD - Bangladesh 126
IE - Irlanda 112
AR - Argentina 61
MX - Messico 56
JP - Giappone 54
CI - Costa d'Avorio 47
SE - Svezia 47
KR - Corea 46
ZA - Sudafrica 39
IQ - Iraq 35
PH - Filippine 35
ID - Indonesia 32
PL - Polonia 32
AT - Austria 27
ES - Italia 24
EC - Ecuador 22
TH - Thailandia 22
TR - Turchia 22
UZ - Uzbekistan 18
BE - Belgio 15
PK - Pakistan 15
CO - Colombia 14
VE - Venezuela 14
BG - Bulgaria 13
TW - Taiwan 13
PE - Perù 12
PY - Paraguay 12
AE - Emirati Arabi Uniti 11
CL - Cile 11
IL - Israele 11
MY - Malesia 11
CR - Costa Rica 10
JM - Giamaica 10
IR - Iran 9
MA - Marocco 9
TT - Trinidad e Tobago 9
EG - Egitto 8
SA - Arabia Saudita 8
CH - Svizzera 7
KE - Kenya 7
TN - Tunisia 7
AL - Albania 6
BB - Barbados 6
JO - Giordania 6
GT - Guatemala 5
GY - Guiana 5
LT - Lituania 5
NP - Nepal 5
PT - Portogallo 5
RO - Romania 5
SI - Slovenia 5
UY - Uruguay 5
BY - Bielorussia 4
CZ - Repubblica Ceca 4
EE - Estonia 4
EU - Europa 4
PA - Panama 4
AM - Armenia 3
AO - Angola 3
AZ - Azerbaigian 3
BO - Bolivia 3
DK - Danimarca 3
KZ - Kazakistan 3
LA - Repubblica Popolare Democratica del Laos 3
PR - Porto Rico 3
SK - Slovacchia (Repubblica Slovacca) 3
BH - Bahrain 2
DJ - Gibuti 2
DM - Dominica 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GA - Gabon 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
HT - Haiti 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
MK - Macedonia 2
MN - Mongolia 2
NZ - Nuova Zelanda 2
OM - Oman 2
QA - Qatar 2
Totale 16.135
Salva come PNG Salva come JPEG
Città #
Singapore 1.167
San Jose 868
Ashburn 528
Hong Kong 435
Moscow 425
Beijing 301
Santa Clara 265
Chandler 254
Ho Chi Minh City 238
Hanoi 193
Council Bluffs 188
Hefei 184
Naples 175
The Dalles 147
Millbury 145
Lauterbourg 142
Los Angeles 138
Jacksonville 113
Amsterdam 111
Princeton 104
Boston 92
Buffalo 79
Nanjing 79
New York 70
Napoli 66
Dallas 59
São Paulo 56
Redondo Beach 53
Munich 52
Ottawa 51
Woodbridge 50
Wilmington 49
Houston 45
Haiphong 44
Tokyo 42
Des Moines 37
Orem 37
Da Nang 36
Kochi 35
Lawrence 35
Toronto 34
London 33
Phoenix 33
Seoul 33
Frankfurt am Main 32
Milan 31
Brooklyn 30
Atlanta 29
Seattle 28
Nuremberg 26
Rome 26
Dublin 25
Helsinki 25
Nanchang 25
Washington 24
Denver 23
Montreal 23
Warsaw 23
Rio de Janeiro 22
Tianjin 21
Dong Ket 20
Hebei 20
Johannesburg 20
Mexico City 20
Chicago 19
San Giovanni Rotondo 19
Chennai 18
Jiaxing 18
San Francisco 18
Lappeenranta 17
Stockholm 16
Turku 16
Hải Dương 15
Baghdad 14
Biên Hòa 14
Falls Church 14
Norwalk 14
Tashkent 14
Changsha 13
Memphis 13
Shenyang 12
Sofia 12
Vienna 12
Brasília 11
Curitiba 11
Dhaka 11
Manchester 11
Ninh Bình 11
Mumbai 10
San José 10
Hangzhou 9
Poplar 9
Porto Alegre 9
San Mateo 9
Courcelles 8
Falkenstein 8
Guangzhou 8
Guayaquil 8
Kunming 8
New Delhi 8
Totale 8.261
Salva come PNG Salva come JPEG
Nome #
Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status 546
Bone marker and bone density responses to dopamine agonist therapy in hyperprolactinemic males 203
Type 2 Deiodinase Thr92Ala Polymorphism and Aging Are Associated with a Decreased Pituitary Sensitivity to Thyroid Hormone 186
Added prognostic value of left ventricular shape by gated SPECT imaging in patients with suspected coronary artery disease and normal myocardial perfusion 168
Long-term management of lenvatinib-treated thyroid cancer patients: a real-life experience at a single institution 166
Combined evaluation of regional coronary artery calcium and myocardial perfusion by 82Rb PET/CT in the identification of obstructive coronary artery disease 164
Comparison between computed tomography multislice and high-field magnetic resonance in the diagnostic evaluation of patients with renal masses 162
Combination of Lenvatinib and Pembrolizumab as Salvage Treatment for Paucicellular Variant of Anaplastic Thyroid Cancer: A Case Report 162
Quantification of Coronary Artery Atherosclerotic Burden and Muscle Mass: Exploratory Comparison of Two Freely Available Software Programs 159
Assessment of acute myocarditis by cardiac magnetic resonance imaging: Comparison of qualitative and quantitative analysis methods 155
Imaging medullary thyroid cancer patients with detectable serum markers: state of the art and future perspectives 155
Management of differentiated thyroid cancer through nuclear medicine facilities during Covid-19 emergency: the telemedicine challenge 154
The Safety and Efficacy of Peptide Receptor Radionuclide Therapy for Gastro-Entero-Pancreatic Neuroendocrine Tumors: A Single Center Experience 153
Prediction of 2-[18F]FDG PET-CT SUVmax for Adrenal Mass Characterization: A CT Radiomics Feasibility Study 152
Prognostic Value of Hybrid PET/MR Imaging in Patients with Differentiated Thyroid Cancer 152
Whole-body radioiodine effective half-life in patients with differentiated thyroid cancer 151
Tumor Burden of Iodine-Avid Bone Metastatic Thyroid Cancer Identified via 18F-Sodium Fluoride PET/CT Imaging 147
Diagnosis, Management and Theragnostic Approach of Gastro-Entero-Pancreatic Neuroendocrine Neoplasms 147
First-line systemic therapy for metastatic castration-sensitive prostate cancer: An updated systematic review with novel findings 146
La scintigrafia con 131I metaiodobenzilguanidina in pazienti con sospetto feocromocitoma: confronto con TC e parametri bioumorali 144
Risk of structural persistent disease in pediatric patients with low or intermediate risk differentiated thyroid cancer 144
The role of dynamic post-contrast T1-w MRI sequence to characterize lipid-rich and lipid-poor adrenal adenomas in comparison to non-adenoma lesions: preliminary results 143
Ablation rate after radioactive iodine therapy in patients with differentiated thyroid cancer at intermediate or high risk of recurrence: a systematic review and a meta-analysis 141
Minimally invasive percutaneous treatment for osteoid osteoma of the Spine. A case report 140
Advances in functional imaging of differentiated thyroid cancer 137
Qualitative heterogeneous signal drop on chemical shift (Cs) mr imaging: Correlative quantitative analysis between cs signal intensity index and contrast washout parameters using t1-weighted sequences 137
Long-term prognostic value of the response to therapy assessed by laboratory and imaging findings in patients with differentiated thyroid cancer 136
Insights into Myocardial Perfusion PET Imaging: the Coronary Flow Capacity 133
Higher baseline TSH levels predict early hypothyroidism during cancer immunotherapy 132
Impairment of bone status in patients with central diabetes insipidus 132
Comparison of simultaneous 18F-2-[18F] FDG PET/MR and PET/CT in the follow-up of patients with differentiated thyroid cancer 132
Outcome of Patients With Differentiated Thyroid Cancer Treated With 131-Iodine on the Basis of a Detectable Serum Thyroglobulin Level After Initial Treatment 131
Second Primary Malignancies in Patients with Differentiated Thyroid Cancer after Radionuclide Therapy: A Retrospective Single-Centre Study 130
Initial Testing of an Approximated, Fast Calculation Procedure for Personalized Dosimetry in Radionuclide Therapy Based on Planar Whole-Body Scan and Monte-Carlo Specific Dose Rates from the OpenDose Project 130
Current Advances in Radioactive Iodine-Refractory Differentiated Thyroid Cancer 129
La scintigrafia surrenalica con indio-111 octreotide in un caso di feocromocitoma maligno: confronto tra tecnica planare e tomografica (SPECT) 129
Intramedullary Spinal Cord Metastases from Differentiated Thyroid Cancer, a Case Report 129
External validation of a predictive model for post-treatment persistent disease by 131I whole-body scintigraphy in patients with differentiated thyroid cancer 128
Efficacy of Empirical Radioiodine Therapy in Patients with Differentiated Thyroid Cancer and Elevated Serum Thyroglobulin without Evidence of Structural Disease: A Propensity Score Analysis 128
MR imaging characterization of pheochromocytoma: a comparison between typical and atypical tumor lesions 126
Combined therapy of Sr-89 and zoledronic acid in patients with painful bone metastases. 126
Incremental value of sestamibi SPECT/CT over dual-phase planar scintigraphy in patients with primary hyperparathyroidism and inconclusive ultrasound 125
Pancreatic Neuroendocrine Tumors in patients with Multiple Endocrine Neoplasia Type 1: Diagnostic Value of Different MRI Sequences 124
Risk of primary breast cancer in patients with differentiated thyroid cancer undergoing radioactive iodine therapy: a systematic review and meta-analysis 124
Prognostic value of 12-month response to therapy in pediatric patients with differentiated thyroid cancer 123
Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients. 123
Postsurgical diagnostic evaluation of patients with differentiated thyroid carcinoma: comparison of ultrasound, iodine-131 scintigraphy and PET with fluorine-18 fluorodeoxyglucose. 123
The diagnostic role of total-body 18F-FDG PET/CT in patients with multiple tumors: a report of the association of thyroid cancer with lung or renal tumors 123
Prognostic role of 18F-FDG PET/CT in the postoperative evaluation of differentiated thyroid cancer patients 121
Emerging Role of Nuclear Medicine in Prostate Cancer: Current State and Future Perspectives 120
Assessment of metabolic response to radioimmunotherapy with 90Y-ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma 120
Diagnostic Accuracy of Gd-EOB-DTPA for Detection Hepatocellular Carcinoma (HCC): A Comparative Study with Dynamic Contrast Enhanced Magnetic Resonance Imaging (MRI) and Dynamic Contrast Enhanced Computed Tomography (CT) 120
Subclinical hyperthyroidism: clinical features and treatment options. 119
Valutazione morfo-funzionale del rene nella fibrosi retroperitoneale: correlazioni tra tomografia computerizzata, risonanza magnetica e scintigrafia renale dinamica 119
Effects of two years of growth hormone (GH) replacement therapy on bone metabolism and mineral density in childhood and adulthood onset GH deficient patients 118
A case of an elderly patient with advanced disease and non-radioiodine-avid metastases 115
Role of serial cardiac 18F-FDG PET-MRI in Anderson-Fabry disease: a pilot study 114
Hyperfunctioning parathyroid gland and skeletal involvement on [18F]fluorocholine PET/CT: one look with two views 112
Effect of a short-term treatment with alendronate on bone density and bone markers in patients with central diabetes insipidus 111
Combined bone scintigraphy and fluorocholine PET/computed tomography predicts response to radium-223 therapy in patients with prostate cancer 111
Characterization with hybrid imaging of cystic pheochromocytomas: Correlation with pathology 111
La tomografia a emissione di positroni (PET) con F-18 FDG nello studio delle formazioni espansive a sede surrenalica: confronto tra lesioni benigne e maligne 110
Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study 109
Characterization of Atypical Pheochromocytomas with Correlative MRI and Planar/Hybrid Radionuclide Imaging: A Preliminary Study 108
111In-pentetreotide scintigraphy in the post-thyroidectomy follow-up of patients with medullary thyroid carcinoma 106
Cardovascular safety of acute recombinant human thyrotropin administration in patients monitored for differentiated thyroid cancer. 104
“Ruolo della PET (tomografia ad emissione di positroni) con 2-(18F)Fluoro-2-Desossiglucosio (FDG) nel carcinoma differenziato della tiroide” 104
Cardiac hybrid imaging: novel tracers for novel targets 103
Valutazione diagnostica post-chirurgica di pazienti con carcinoma tiroideo differenziato: confronto tra ecografia, scintigrafia con iodio-131 e PET con fluoro-18 fluorodesossiglucosio. 99
Utilizzo del TSH ricombinante nella diagnostica del carcinoma differenziato della tiroide:trials multicentrici di validazione 99
Preclinical imaging for the study of mouse models of thyroid cancer 97
Caratterizzazione scintigrafica delle lesioni espansive a sede surrenalica: confronto con l'imaging a risonanza magnetica 96
The role of radiolabeled somatostatin analogs in adrenal imaging. 96
Metastatic castration‑resistant prostate cancer therapy: the quest for the perfect molecule 95
Expanding the long‑axial feld‑of‑view PET‑CT horizons: unveiling new arrows in our quiver 94
Diagnostica integrata del feocromocitoma 93
L'incidenza della scoliosi in rapporto a disturbi endocrini nell'età evolutiva 93
PET/CT in the management of differentiated thyroid cancer 93
131I-meta-iodobenzylguanidine scintigraphy in patients with a suspected pheochromocytoma. A comparison with CT and biohumoral parameters 92
Role of the neck ultrasonography, of thyroglobulin after rhTSH and of FDGPET in post surgical follow-up of differentiated thyroid cancer 92
Non-Hodgkin's lymphoma in a patient with follicular thyroid cancer: the role of Tc-99m methoxy isobutyl isonitrile imaging 91
New opportunities for dosimetric approach in patients with differentiated thyroid cancer 91
Parathyroid scintigraphy with 99mTc-MIBI in hyperparathyroidism. A comparison between diagnostic imaging technics in the location and characterization of glandular hyperfunction and in the evaluation of skeletal changes 90
Diagnostic evaluation of thyroid involvement by histiocytosis X. 90
Total thyroidectomy, without prophylactic central lymph node dissection, in the treatment of differentiated thyroid cancer. Clinical retrospective study on 221 cases. 90
The use of recombinant human TSH in the follow-up of differentiated thyroid thyroid cancer: experience from a large pateint cohort in a single centre. 89
Tetrofosmin thyroid scintigraphy 88
The role of radiolabeled somatostatin analogs in adrenal imaging. 88
Tc-99m MIBI imaging in the initial diagnosis and post-surgery follow-up of patients with thyroid cancer 88
Cardiovascular safety of acute recombinant human thyrotropin administration to patients monitored for differentiated thyroid cancer. 87
Comparison of labeled MIBG and somatostatin analogs in imaging neuroendocrine tumors 86
Diagnostic accuracy of radionuclide imaging using 131I nor-cholesterol or meta-iodobenzylguanidine in patients with hypersecreting or non-hypersecreting adrenal tumours. 85
Growth hormone deficiency in elderly patients with hypothalamo-pituitary tumors 84
Radionuclide imaging of neuroendocrine tumors: a comparative study using radiolabeled MIBG and octreotide. 84
Familial pheochromocytoma in Sipple's syndrome. A comparison between scintigraphy with 131I-meta-iodobenzylguanidine, computed tomography and echography 83
The current and evolving role of FDG–PET/CT in personalized iodine-131 therapy of differentiated thyroid cancer 82
Prognostic role of FDG PET/CT in patients with differentiated thyroid cancer treated with 131-iodine empiric therapy 81
[Adrenal scintigraphy with Indium-111 octreotide in a case of malignant pheochromocytoma: comparison of the planar and tomographic technique (SPECT)]. 79
Technetium-99m-tetrofosmin imaging of differentiated mixed thyroid cancer 78
Diagnostic accuracy of radionuclide imaging using iodine-131 nor-cholesterol or MIBG in patients with hypersecreting or non-hypersecreting adrenal tumors. 78
Totale 12.336
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.226
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.226
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022760 0 0 0 27 25 15 9 35 108 34 161 346
2022/2023728 141 37 24 30 92 74 7 69 87 107 41 19
2023/2024758 40 89 76 74 52 83 29 66 17 18 136 78
2024/20253.952 210 268 10 12 103 242 448 242 310 425 1.371 311
2025/20267.482 860 575 811 708 1.262 257 779 468 865 513 176 208
2026/20271.302 595 306 371 30 0 0 0 0 0 0 0 0
Totale 16.406